Andrea Zaťková

Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment

L. Ranganath, Anna M. Milan, Andrew T. Hughes et al. · Annals of the Rheumatic Diseases · 2014 · 155 citations · Full text

Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial

L. Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux et al. · The Lancet Diabetes & Endocrinology · 2020 · 119 citations · Full text

Once-daily Nitisinone, Urological Research, Pharmacology +3

Amplification and overexpression of the <i>IGF2</i> regulator <i>PLAG1</i> in hepatoblastoma

Andrea Zaťková, Jean‐Marie Rouillard, Wolfgang Hartmann et al. · Genes Chromosomes and Cancer · 2003 · 114 citations

Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on ‘black bone disease’ in Italy

Martina Nemethova, Ján Radvánszky, Ľudevít Kádaši et al. · European Journal of Human Genetics · 2015 · 102 citations · Full text

Genetic Disorder, Alkaptonuria Patients, Genetics +8

An update on molecular genetics of Alkaptonuria (AKU)

Andrea Zaťková · Journal of Inherited Metabolic Disease · 2011 · 102 citations